A new trading day began on Monday, with Lineage Cell Therapeutics Inc (AMEX: LCTX) stock price up 3.24% from the previous day of trading, before settling in for the closing price of $0.58. LCTX’s price has ranged from $0.48 to $1.61 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 148.63%. Meanwhile, its annual earnings per share averaged 8.33%. With a float of $219.17 million, this company’s outstanding shares have now reached $220.42 million.
Let’s determine the extent of company efficiency that accounts for 75 employees. In terms of profitability, gross margin is 90.99%, operating margin of -260.7%, and the pretax margin is -229.91%.
Lineage Cell Therapeutics Inc (LCTX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Lineage Cell Therapeutics Inc is 0.57%, while institutional ownership is 43.59%. The most recent insider transaction that took place on Nov 26 ’24, was worth 8,850. In this transaction Chief Financial Officer of this company bought 15,000 shares at a rate of $0.59, taking the stock ownership to the 25,500 shares. Before that another transaction happened on Nov 26 ’24, when Company’s General Counsel bought 15,000 for $0.60, making the entire transaction worth $9,000. This insider now owns 22,184 shares in total.
Lineage Cell Therapeutics Inc (LCTX) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 8.33% per share during the next fiscal year.
Lineage Cell Therapeutics Inc (AMEX: LCTX) Trading Performance Indicators
Here are Lineage Cell Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 15.14.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.11, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.10 in one year’s time.
Technical Analysis of Lineage Cell Therapeutics Inc (LCTX)
Looking closely at Lineage Cell Therapeutics Inc (AMEX: LCTX), its last 5-days average volume was 1.65 million, which is a drop from its year-to-date volume of 3.71 million. As of the previous 9 days, the stock’s Stochastic %D was 69.79%. Additionally, its Average True Range was 0.05.
During the past 100 days, Lineage Cell Therapeutics Inc’s (LCTX) raw stochastic average was set at 24.09%, which indicates a significant decrease from 92.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 102.18% in the past 14 days, which was higher than the 94.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6518, while its 200-day Moving Average is $0.9136. However, in the short run, Lineage Cell Therapeutics Inc’s stock first resistance to watch stands at $0.6171. Second resistance stands at $0.6353. The third major resistance level sits at $0.6714. If the price goes on to break the first support level at $0.5628, it is likely to go to the next support level at $0.5267. Now, if the price goes above the second support level, the third support stands at $0.5085.
Lineage Cell Therapeutics Inc (AMEX: LCTX) Key Stats
With a market capitalization of 131.99 million, the company has a total of 220,416K Shares Outstanding. Currently, annual sales are 8,950 K while annual income is -21,490 K. The company’s previous quarter sales were 3,780 K while its latest quarter income was -3,030 K.
